MacroGenics | MGNX - Modal Pinjaman





Modal Pinjaman Perubahan Tanggal
AbbVie USD 58.94B 4.03B 2025-12
Amgen USD 50B 2.43B 2025-12
AstraZeneca USD 25.96B 177M 2026-03
Biogen USD 6.29B 1.7M 2026-03
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Daiichi Sankyo JPY 300.15B 199.41B 2025-12
Eli Lilly USD 40.87B 5.6M 2025-12
Genmab DKK 5.14B 5.01B 2025-12
Geron USD 119.55M 283K 2025-12
Gilead Sciences USD 22.13B 6M 2025-12
J&J USD 37.53B 1.91B 2026-03
Karyopharm Therapeutics USD 278.22M 278.22M 2025-12
MacroGenics USD 70M 256K 2025-12
Merck USD 39.97B 6B 2025-09
Pfizer USD 57.41B 93M 2025-09
Puma Biotechnology USD 10.87M 222K 2025-06
Regeneron Pharmaceuticals USD 1.99B 719.7M 2026-03
Roche Holding CHF 27.43B 966M 2025-12
Xencor USD 76.48M 11.29M 2025-12